Stage III Prostate Cancer AJCC v8 (DBCOND0109669)

Identifiers

Synonyms
Not Available

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT04514484
Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVtreatment1active_not_recruiting
NCT03899987
Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgerytreatment2suspended
NCT03630354
EXERCISING TOGETHER for Couples Coping With CancerNo drug interventionssupportive_careNot Availablecompleted
NCT04037254
Niraparib With Standard Combination Radiation Therapy and Androgen Deprivation Therapy in Treating Patients With High Risk Prostate Cancertreatment2active_not_recruiting
NCT03784677
A Phase I Study of SOR-C13 in Patients With Advanced Solid Tumorstreatment1completed
NCT04457245
Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate CancerNo drug interventionsdiagnostic3terminated
NCT05722288
Time-Restricted Eating Versus Nutritional Counseling for the Reduction of Radiation or Chemoradiation Tx Side Effects in Patients With Prostate, Cervical, or Rectal CancersNo drug interventionssupportive_care2recruiting
NCT03581500
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Response in Patients With Prostate CancerNo drug interventionsdiagnostic2active_not_recruiting
NCT04927559
Health Literacy in Understanding Radiation Therapy Information in Patients Undergoing Definitive Radiation TherapyNo drug interventionsNot AvailableNot Availableterminated
NCT05946213
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate CancerNo drug interventionstreatment3recruiting
NCT05838716
High-Dose Vitamin D Supplementation for ADT-Induced Bone Loss in Older Prostate Cancer PatientsNo drug interventionssupportive_care3recruiting
NCT06205316
SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate AdenocarcinomaNo drug interventionstreatment3recruiting
NCT03987386
Conventional or Hypofractionated Radiation Therapy in Treating Patients With Prostate CancerNo drug interventionstreatment3recruiting
NCT05869682
Bright White Light Therapy in Reducing Cancer-Related Fatigue and Depression in Advanced Prostate Cancer Patients Undergoing Treatment With ADT Combination TherapyNo drug interventionssupportive_care2recruiting
NCT03570827
Hypofractionated Radiation Therapy for Treating Prostate Cancer High-Risk Features Following Radical ProstatectomyNo drug interventionstreatment2active_not_recruiting
NCT04134260
Testing the Addition of the Drug Apalutamide to the Usual Hormone Therapy and Radiation Therapy After Surgery for Prostate Cancertreatment3recruiting
NCT06173362
Abiraterone and Prednisone or Darolutamide for the Treatment of Advanced Prostate Cancertreatment2recruiting
NCT05877144
Low-Intensity Shockwave Therapy to Treat Erectile Dysfunction and Preserve Erectile Function After Prostate Cancer SurgeryNo drug interventionstreatmentNot Availablerecruiting
NCT06500169
Golf Recreational Exercise for Enhanced Survivorship in Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availablerecruiting
NCT05487846
Peer Navigation for the Support of Metastatic Prostate Cancer Patients Undergoing Genetic EvaluationNo drug interventionshealth_services_researchNot Availablenot_yet_recruiting
NCT06325046
Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04725903
Proton Radiation Therapy for the Treatment of Patients With High Risk Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT04947254
Androgen Ablation Therapy With or Without Niraparib After Radiation Therapy for the Treatment of High-Risk Localized or Locally Advanced Prostate Cancertreatment2recruiting
NCT06129851
Relugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate Cancertreatment2not_yet_recruiting
NCT04318028
An Investigational Scan (7 Tesla MRI) in Diagnosing Cognitive Impairment in Patients With Non-Metastatic Prostate CancerNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT03575832
Watchful Living in Improving Quality of Life in Participants With Localized Prostate Cancer on Active Surveillance and Their PartnersNo drug interventionspreventionNot Availableactive_not_recruiting
NCT03582475
Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostatetreatment1completed
NCT04189770
Lifestyle Behavior Influences Among African American Patients With Stage 0-III Prostate Cancer Survivors and Their PartnersNo drug interventionsNot AvailableNot Availablerecruiting
NCT06094842
Autologous T Cells Lentivirally Transduced to Express L1CAM-Specific Chimeric Antigen Receptors in Treating Patients With Locally Advanced and Unresectable or Metastatic Small Cell Neuroendocrine Prostate Cancertreatment1not_yet_recruiting
NCT04945642
High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate AdenocarcinomaNo drug interventionstreatmentNot Availablerecruiting
NCT05320406
RElugolix VErsus LeUprolide Cardiac Trialtreatment4active_not_recruiting
NCT04288336
Daily, Long-Term Intermittent Fasting for the Prevention of PSA-Recurrence in Patients With Localized Prostate Cancer After Radical ProstatectomyNo drug interventionsprevention0withdrawn
NCT04501913
Remote Telemonitoring of Patient-Generated Physiologic Health Data and Patient-Reported OutcomesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04513717
Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trialtreatment3recruiting
NCT04981834
Robot-Assisted Radical Prostatectomy With or Without Vesicopexy in Patients With Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT06389786
Accuracy of 18F-rhPSMA-7.3 PET/ MRI for Prediction of Lymph Node Metastasis in Localized High-Risk Prostate CancerNo drug interventionsscreeningNot Availablerecruiting
NCT06016725
Online Dietary and Resistance Training to Improve Physical Function in Older Cancer Survivors, E-PROOF TrialNo drug interventionssupportive_careNot Availablerecruiting
NCT04976257
Pharmacokinetics of IA and IV Ga68-PSMA-11 Infusiontreatment0completed
NCT03218826
PI3Kbeta Inhibitor AZD8186 and Docetaxel in Treating Patients Advanced Solid Tumors With PTEN or PIK3CB Mutations That Are Metastatic or Cannot Be Removed by Surgerytreatment1active_not_recruiting
NCT03707574
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot StudyNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03177460
Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancertreatment1completed
NCT04067960
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV CancerNo drug interventionsscreening0completed
NCT04550494
Measuring the Effects of Talazoparib in Patients With Advanced Cancer and DNA Repair Variationstreatment2recruiting
NCT04215029
Lifestyle Intervention for the Reduction of Prostate Cancer Disparities Among African AmericansNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT06528210
Pembrolizumab With Androgen Deprivation Therapy and Radiotherapy for the Treatment of Patients With High Risk Localized Prostate Cancertreatment2not_yet_recruiting
NCT06470750
Feasibility of Patient-Centered Home Care (PCHC) to Reduce Disparities in High-Risk Black Men (BM) With Advanced Prostate Cancer (CaP)No drug interventionsNot AvailableNot Availablerecruiting